The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects
Open accessAbstract
In the current practices of anti-infective therapy, ciprofloxacin is a very popular fluoroquinolone having a broad spectrum of activity and diverse therapeutic prospects. The reasons for its wide use include multiresistant pathogens susceptible only to ciprofloxacin. The available clinical evidence suggests the potentially enhanced efficacy of this drug in the treatment of various community acquired and nosocomial infections, e.g. respiratory tract, urinary tract, and skin infections and sexually transmitted diseases. As compared to other agents of its class, the pharmacokinetic profile of ciprofloxacin demonstrates equivalent or greater bioavailability, higher plasma concentrations, and increased tissue penetration, as reflected in the greater volume of distribution. Various molecular modifications of this drug have been made to further improve its characteristics. Several methods of analytical determination of ciprofloxacin and its metabolites in biological fluids employing various techniques have been reported. The present article is focused on the synthetic development, pharmacotherapeutic, and analytical evaluation vistas of ciprofloxacin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Fraunfelder, F. T. (1981) · American Journal of Ophthalmology · doi:10.1016/0002-9394(81)90318-4 · Cited by 1,331
Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Chen, D. K., McGeer, A., de Azavedo, J. C., & Low, D. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410403 · Cited by 987
An Introduction to Medicinal Chemistry
Patrick, G. L. (2023) · Oxford University Press eBooks · doi:10.1093/hesc/9780198866664.001.0001 · Cited by 756
DNA Gyrase and the Supercoiling of DNA
Cozzarelli, N. R. (1980) · Science · doi:10.1126/science.6243420 · Cited by 711
The fluoroquinolone antibacterials: past, present and future perspectives
Appelbaum, P. C., & Hunter, P. A. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00192-8 · Cited by 629
Burger's Medicinal Chemistry and Drug Discovery
Abraham, D. J. (2003) · Wiley eBooks · doi:10.1002/0471266949 · Cited by 499
Quinolones: a comprehensive review.
Oliphant, C. M., & Green, G. M. (2002) · PubMed · Cited by 454
Liu, L., Guo, K., Lu, J., Venkatraman, S. S., Luo, D., Ng, K. C., Ling, E.-A., Moochhala, S., & Yang, Y.-Y. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.014 · Cited by 246
Ho, P.-L., Que, T.-L., Tsang, D. N.-C., Ng, T.-K., Chow, K.-H., & Seto, W.-H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1310 · Cited by 241
DEKKER, A. W., ROZENBERG-ARSKA, M., & VERHOEF, J. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-1-7 · Cited by 230
Wetzstein, H.-G., Stadler, M., Tichy, H.-V., Dalhoff, A., & Karl, W. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.4.1556-1563.1999 · Cited by 196
Samanidou, V. F., Demetriou, C. E., & Papadoyannis, I. N. (2003) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-003-1749-9 · Cited by 188
Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells
Herold, C., Ocker, M., Ganslmayer, M., Gerauer, H., Hahn, E. G., & Schuppan, D. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600079 · Cited by 188
Lubasch, A., Keller, I., Borner, K., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2600-2603.2000 · Cited by 186
Quinolones: a class of antimicrobial agents
Sárközy, G. (2001) · Veterinární Medicína · doi:10.17221/7883-vetmed · Cited by 178
Cassell, G. H. (2001) · JAMA · doi:10.1001/jama.285.5.601 · Cited by 162
Aranha, O., Wood, D. P., & Sarkar, F. H. (2000) · PubMed · Cited by 124
Preformed microcapsules for loading and sustained release of ciprofloxacin hydrochloride
Mao, Z., Ma, L., Gao, C., & Shen, J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.005 · Cited by 124
Principles of Pharmacology: Basic Concepts and Clinical Applications
Munson, P. L., Mueller, R. A., Breese, G. R., & Breese, G. R. (1996) · Medical Entomology and Zoology · Cited by 123
Joos, B., Ledergerber, B., Flepp, M., Bettex, J.-D., Luthy, R. P., & Siegenthaler, W. E. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.353 · Cited by 112
Schmitz, F., Hofmann, B., Hansen, B., Scheuring, S., Lückefahr, M., Klootwijk, M., Verhoef, J., Fluit, A., Heinz, H. P., Köhrer, K., et al. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.4.481 · Cited by 108
Aranha, O., Grignon, R., Fernandes, N., McDonnell, T. J., Wood, D. P., & Sarkar, F. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.4.787 · Cited by 99
Tyczkowska, K. L., Hedeen, K. M., Aucoin, D. P., & Aronson, A. L. (1989) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)82739-5 · Cited by 97
Foroumadi, A., Ghodsi, S., Emami, S., Najjari, S., Samadi, N., Faramarzi, M. A., Beikmohammadi, L., Shirazi, F. H., & Shafiee, A. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.103 · Cited by 92
Azéma, J., Guidetti, B., Dewelle, J., Calvé, B. L., Mijatovic, T., Korolyov, A., Vaysse, J., Malet‐Martino, M., Martino, R., & Robert Kiss, A. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.053 · Cited by 90
Foroumadi, A., Emami, S., Mehni, M., Moshafi, M. H., & Shafiee, A. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.005 · Cited by 78
Pham, H. H., Luo, P., Génin, F., & Dash, A. K. (2002) · AAPS PharmSciTech · doi:10.1208/pt030101 · Cited by 75
Liquid-chromatographic determination of ciprofloxacin in serum and urine.
Nix, D., Vito, J. M. D., & Schentag, J. J. (1985) · Clinical Chemistry · doi:10.1093/clinchem/31.5.684 · Cited by 71
Trimethoprim/Sulfamethoxazole Resistance in Urinary Tract Infections
Güneysel, Ö., Onur, Ö., Erdede, M., & Denizbaşı, A. (2008) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2007.08.068 · Cited by 69
German, N., Wei, P., Kaatz, G. W., & Kerns, R. J. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.01.042 · Cited by 68
Antibacterial Chemotherapeutic Agents
Dax, S. L. (1997) · Springer eBooks · doi:10.1007/978-94-009-0097-4 · Cited by 58
Kerns, R. J., Rybak, M. J., Kaatz, G. W., Vaka, F., Cha, R., Grucz, R. G., Diwadkar, V. U., & Ward, T. D. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00208-7 · Cited by 54
Bakker‐Woudenberg, I. A. J. M., ten Kate, M. T., Guo, L., Working, P. K., & Mouton, J. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1487-1492.2001 · Cited by 54
Cerebrospinal Fluid Penetration of High Doses of Intravenous Ciprofloxacin in Meningitis
Lipman, J., Allworth, A. M., & Wallis, S. C. (2000) · Clinical Infectious Diseases · doi:10.1086/317462 · Cited by 52
Mechanisms of Fluoroquinolone Transport by Human Neutrophils
Walters, J. D., Zhang, F., & Nakkula, R. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2710 · Cited by 48
Yan, H., Tian, M., & Row, K. H. (2008) · Journal of Separation Science · doi:10.1002/jssc.200800315 · Cited by 48
Foroumadi, A., Oboudiat, M., Emami, S., Karimollah, A., Saghaei, L., Moshafi, M. H., & Shafiee, A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.058 · Cited by 46
Sriram, D., Yogeeswari, P., Senchani, G., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.055 · Cited by 44
Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro
Polachek, H., Holcberg, G., Sapir, G., Tsadkin-Tamir, M., Polachek, J., Katz, M. E., & Ben‐Zvi, Z. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.11.031 · Cited by 43
Bourikas, L. A., Kolios, G. C., Valatas, V., Notas, G., Drygiannakis, I., Pelagiadis, I., Manousou, P., Klironomos, S., Mouzas, I., & Kouroumalis, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00161.x · Cited by 38
Pinto, A. C. R., Moreira, J. N., & Simões, S. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0892-6 · Cited by 33
Theophylline and Warfarin Interaction Studies with Grepafloxacin
Efthymiopoulos, C., Bramer, S. L., Maroli, A. N., et al. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199700331-00008 · Cited by 32
Norfloxacin: Its potential in clinical practice
Lee, C. R., & Ronald, A. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90615-2 · Cited by 24
Norfloxacin : A Therapeutic Review
Ch, P., Sharma, E., Saneja, A., et al. (2008) · International Journal of Chemical Sciences · Cited by 22
Al‐Soud, Y. A., & Al-Masoudi, N. A. (2003) · Journal of the Brazilian Chemical Society · doi:10.1590/s0103-50532003000500014 · Cited by 21
Brünner, H., & Zeiler, H. J. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.1.57 · Cited by 20
Ciprofloxacin interacts with thyroid replacement therapy
Cooper, J. G., Harboe, K., Frost, S. K., & Skadberg, Ø. (2005) · BMJ · doi:10.1136/bmj.330.7498.1002 · Cited by 15
Cited by
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
Targeting renal fibrosis: Mechanisms and drug delivery systems
Nastase, M. V., Zeng-Brouwers, J., Wygrecka, M., & Schaefer, L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.019 · Cited by 302
Medicinal significance of benzothiazole scaffold: an insight view
Sharma, P. C., Sinhmar, A., Sharma, A., Rajak, H., & Pathak, D. P. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.720572 · Cited by 256
Self-citation
Metadata
- Authors
- Sharma, P. C., Jain, A., Jain, S., Pahwa, R., & Yar, M. S.
- Venue
- Journal of Enzyme Inhibition and Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2010-03-17
- Volume
- 25
- Issue
- 4
- Pages
- 577-589
- ISSN
- 1475-6366 (ISSN-L)
- 1475-6374
- OpenAlex
- W2139554217
- Cited by
- 353
- References
- 49
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.